Multiple roles for HIV broadly neutralizing antibodies.
Journal
Science translational medicine
ISSN: 1946-6242
Titre abrégé: Sci Transl Med
Pays: United States
ID NLM: 101505086
Informations de publication
Date de publication:
30 10 2019
30 10 2019
Historique:
received:
16
09
2019
accepted:
11
10
2019
entrez:
1
11
2019
pubmed:
2
11
2019
medline:
5
9
2020
Statut:
ppublish
Résumé
Potent broadly neutralizing antibodies may be used to treat or prevent HIV and to help guide HIV vaccine design.
Identifiants
pubmed: 31666399
pii: 11/516/eaaz2686
doi: 10.1126/scitranslmed.aaz2686
pmc: PMC7171597
mid: NIHMS1577790
pii:
doi:
Substances chimiques
AIDS Vaccines
0
Broadly Neutralizing Antibodies
0
HIV Antibodies
0
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, N.I.H., Intramural
Review
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : NIAID NIH HHS
ID : UM1 AI144371
Pays : United States
Organisme : NIAID NIH HHS
ID : UM1 AI144462
Pays : United States
Informations de copyright
Copyright © 2019 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works.
Références
Nat Med. 2019 Apr;25(4):547-553
pubmed: 30936546
Cell Host Microbe. 2017 Aug 9;22(2):207-216
pubmed: 28799906
Immunol Rev. 2017 Jan;275(1):161-182
pubmed: 28133806
Cell Host Microbe. 2016 Mar 9;19(3):292-303
pubmed: 26922989
Nat Biotechnol. 2012 May 07;30(5):423-33
pubmed: 22565972
Immunol Rev. 2013 Jul;254(1):225-44
pubmed: 23772623
Curr Opin Virol. 2013 Jun;3(3):322-31
pubmed: 23806515
Immunity. 2018 May 15;48(5):855-871
pubmed: 29768174
Cold Spring Harb Perspect Biol. 2017 Nov 1;9(11):
pubmed: 28159875
Nat Immunol. 2018 Nov;19(11):1179-1188
pubmed: 30333615